glp-1 industry What is the future of trends: PwC Boom in GLP-1 drugs augurs
Description
Willard, J.D
Plasma levels of OXA are increased during fasting in humans (32) and are lower in obese subjects than normal-weight people (33), suggesting that peripheral OXA modulates food intake as an orexigenic peptide (34)
Experience in practise I have limited experience with clients taking these medications in practice, however I do have some experience
NICE in the UK recommends a maximum of two years for semaglutide (Wegovy), though no such limit exists for tirzepatide (Mounjaro)
Tirzepatide was approved by the FDA for the treatment of diabetes in May 2022 and a few months later in the European Union, Canada and Australia
If you are struggling with dietary compliance, say so
